162 related articles for article (PubMed ID: 8222103)
1. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study.
White HD; Barbash GI; Modan M; Simes J; Diaz R; Hampton JR; Heikkilä J; Kristinsson A; Moulopoulos S; Paolasso EA
Circulation; 1993 Nov; 88(5 Pt 1):2097-103. PubMed ID: 8222103
[TBL] [Abstract][Full Text] [Related]
2. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Circulation; 1993 Jan; 87(1):53-8. PubMed ID: 8419024
[TBL] [Abstract][Full Text] [Related]
3. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Van de Werf F
J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
5. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
[TBL] [Abstract][Full Text] [Related]
6. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Van de Werf F
J Am Coll Cardiol; 1992 Jul; 20(1):36-41. PubMed ID: 1607536
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Califf RM; Ellis SG; Sigmon KN; Lee KL; Leimberger JD; Topol EJ
J Am Coll Cardiol; 1993 Dec; 22(7):1780-7. PubMed ID: 8245328
[TBL] [Abstract][Full Text] [Related]
8. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
Barbash GI; Birnbaum Y; Bogaerts K; Hudson M; Lesaffre E; Fu Y; Goodman S; Houbracken K; Munsters K; Granger CB; Pieper K; Califf RM; Topol EJ; Van De Werf F
Circulation; 2001 Feb; 103(7):954-60. PubMed ID: 11181469
[TBL] [Abstract][Full Text] [Related]
9. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
Granger CB; Califf RM; Young S; Candela R; Samaha J; Worley S; Kereiakes DJ; Topol EJ
J Am Coll Cardiol; 1993 Mar; 21(4):920-5. PubMed ID: 8450161
[TBL] [Abstract][Full Text] [Related]
11. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups.
Tanne D; Gottlieb S; Hod H; Reicher-Reiss H; Boyko V; Behar S
J Am Coll Cardiol; 1997 Nov; 30(6):1484-90. PubMed ID: 9362406
[TBL] [Abstract][Full Text] [Related]
12. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
[TBL] [Abstract][Full Text] [Related]
13. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.
Berger PB; Holmes DR; Stebbins AL; Bates ER; Califf RM; Topol EJ
Circulation; 1997 Jul; 96(1):122-7. PubMed ID: 9236426
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
Am J Cardiol; 1995 May; 75(15):987-92. PubMed ID: 7747700
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women.
Angeja BG; Shlipak MG; Go AS; Johnston SC; Frederick PD; Canto JG; Barron HV; Grady D;
J Am Coll Cardiol; 2001 Nov; 38(5):1297-301. PubMed ID: 11691498
[TBL] [Abstract][Full Text] [Related]
16. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
17. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.
Weaver WD; Simes RJ; Betriu A; Grines CL; Zijlstra F; Garcia E; Grinfeld L; Gibbons RJ; Ribeiro EE; DeWood MA; Ribichini F
JAMA; 1997 Dec; 278(23):2093-8. PubMed ID: 9403425
[TBL] [Abstract][Full Text] [Related]
18. Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis.
O'Connor CM; Califf RM; Massey EW; Mark DB; Kereiakes DJ; Candela RJ; Abbottsmith C; George B; Stack RS; Aronson L
J Am Coll Cardiol; 1990 Sep; 16(3):533-40. PubMed ID: 2117618
[TBL] [Abstract][Full Text] [Related]
19. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
[TBL] [Abstract][Full Text] [Related]
20. Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Eur Heart J; 1995 Mar; 16(3):313-6. PubMed ID: 7789372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
